Long-term follow-up of mTOR inhibition for Erdheim-Chester disease.
Blood
; 135(22): 1994-1997, 2020 05 28.
Article
in En
| MEDLINE
| ID: mdl-32299103
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Erdheim-Chester Disease
/
Protein Kinase Inhibitors
/
TOR Serine-Threonine Kinases
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Blood
Year:
2020
Document type:
Article
Affiliation country:
Italy